Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Pfizer’s Jonathan Emms to be ABPI president

Will take over from MSD's Deepak Khanna in April

Novartis building

Novartis myeloma drug clears phase III trial

Panobinostat on course to be first in new class of treatment for bone marrow cancer

What will pharma’s digital future look like?

Take our 5-minute survey and have your say on the shape of digital marketing in 2014

- PMLiVE

Interview: Mike Hutton, Lilly

Lilly’s chief scientific officer for neurodegenerative diseases talks about his hopes for Alzheimer’s research and making the move from academia to pharma

- PMLiVE

European Court may yet force AbbVie and InterMune to release data

Orders rethink on EMA's Humira and Esbriet injunction

- PMLiVE

Pfizer ups the ante on clinical transparency

Revamps access to data portal

- PMLiVE

Lilly depression drug fails late-stage trials

Will not pursue edivoxetine as an add-on treatment for depression

National Institute for Health and Care Excellence NICE logo

NICE wants more info on Genzyme’s MS drug

UK health guidance body turns down Lemtrada in draft guidance

Evoke Pharma adds to executive team

Appoints new chief medical officer and senior director of clinical operations

translational pharmacology medicine dose

Pharma’s return on R&D spend continues to slide

And cost of launching new medicine rises to $1.3bn says report

- PMLiVE

IMS Health acquires HGS Europe

Founders Graeme and Angela McFarlane bring HGS' market access services to IMS' UK team

- PMLiVE

Teva expects big things from improved drug programme

Aims to market enhanced versions of existing medicines

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links